Tech Company Financing Transactions

ViewPoint Therapeutics Funding Round

On 3/12/2018, ViewPoint Therapeutics raised $35 million in Series B funding from The Rise Fund, BVF Partners and private investors.

Transaction Overview

Announced On
3/12/2018
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series B
Proceeds Purpose
ViewPoint plans to use the proceeds of the financing to develop its lead product candidate, VP1-001, through clinical proof-of-concept studies in patients with cataracts and presbyopia.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
290 Utah Ave. 300
San Francisco, CA 94080
USA
Phone
Undisclosed
Email Address
Overview
ViewPoint Therapeutics is a biotechnology company dedicated to the development of treatments for diseases of protein misfolding, including cataracts.
Profile
ViewPoint Therapeutics LinkedIn Company Profile
Social Media
ViewPoint Therapeutics Company Twitter Account
Company News
ViewPoint Therapeutics News
Facebook
ViewPoint Therapeutics on Facebook
YouTube
ViewPoint Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Medical Officer
Robert Kim
  Robert Kim LinkedIn Profile  Robert Kim Twitter Account  Robert Kim News  Robert Kim on Facebook
Chief Scientific Officer
Leah Makley
  Leah Makley LinkedIn Profile  Leah Makley Twitter Account  Leah Makley News  Leah Makley on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/12/2018: Bird venture capital transaction
Next: 3/12/2018: Interior Define venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary